Literature DB >> 9267955

Effect of ciprofloxacin on the accumulation of interleukin-6, interleukin-8, and nitrite from a human endothelial cell model of sepsis.

H F Galley1, S J Nelson, A M Dubbels, N R Webster.   

Abstract

OBJECTIVE: To determine the effect of the quinolone antibiotic ciprofloxacin, on interleukin-6, interleukin-8, and nitrite production by human endothelial cells.
DESIGN: Controlled cell culture experiments examining the immunomodulatory effects of an antibiotic.
SETTING: University research laboratory attached to a large teaching hospital.
SUBJECTS: A human endothelial cell line.
MEASUREMENTS AND MAIN RESULTS: Cells were incubated with tumor necrosis factor-alpha and interleukin-1beta in the presence of a range of ciprofloxacin concentrations. Interleukin-6, interleukin-8, and nitrite concentrations were measured in culture supernatants after 24 hrs using enzyme immunoassay. Ciprofloxacin decreased interleukin-6 accumulation (p = .001). Interleukin-8 was decreased at lower ciprofloxacin concentrations (p = .017) but was increased at 100 microg/mL (p = .0039). Ciprofloxacin had no effect on nitrite accumulation (p = .38).
CONCLUSIONS: Ciprofloxacin differentially modulates interleukin-6 and interleukin-8 expression. The response to infection is coordinated by a cascade of cytokines and other mediators. The widespread use of ciprofloxacin in patients with severe infections is likely to result in alterations in local concentrations of cytokines. Selective control of cytokine concentrations by antibacterial agents will clearly have important therapeutic implications and may be a future research consideration in antibiotic drug design.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9267955     DOI: 10.1097/00003246-199708000-00029

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

1.  The 6-fluoro-8-methoxy quinolone gatifloxacin down-regulates interleukin-8 production in prostate cell line PC-3.

Authors:  Koh Takeyama; Hiroaki Mitsuzawa; Chiaki Nishitani; Takeyuki Shimizu; Hitomi Sano; Yasuharu Kunishima; Satoshi Takahashi; Hiroshi Hotta; Masanori Matsukawa; Ken-Ichiro Shibata; Taiji Tsukamoto; Yoshio Kuroki
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

Review 2.  Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy.

Authors:  A S Polackwich; D A Shoskes
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-03-08       Impact factor: 5.554

3.  Nonpharmacological approaches for the treatment of urological chronic pelvic pain syndromes in men.

Authors:  Jeannette M Potts
Journal:  Curr Urol Rep       Date:  2009-07       Impact factor: 3.092

4.  Eliminating sedimentation for the treatment of chronic pelvic pain syndrome.

Authors:  Zhongming Sun; Yanzhong Bao
Journal:  Exp Ther Med       Date:  2013-02-27       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.